Botanical species · safety record

Pistacia lentiscus

The EFSA Compendium of Botanicals holds 7 constituent measurements, 1 adverse-effect record and 2 genotoxicity assays for Pistacia lentiscus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Pistacia lentiscus L.

7Constituent measurements
3Safety records
6Cited sources
25Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 25 licensed products naming Pistacia lentiscus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Gum
  • Gum resin
  • Gum-resin
  • Sap
  • Stem bark resin
  • Whole plant

What the records describe

Constituents measured

  • Myrcene3
  • 1,8-cineole1
  • Gallic acid1
  • Saponins1
  • Tannins1

Plant parts

  • Aerial part of plants4
  • Leaves2
  • Fruit unspecified1
  • Seed1

Preparations

  • Solvent extraction6
  • Essential oil2

Effect types

  • Systemic1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Gallic acidFruit unspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
MyrceneAerial part of plantsEssential oil≤ 57.59 PercentGC-MSResolve DOI
MyrceneAerial part of plantsEssential oil≥ 0.67 PercentGC-MSResolve DOI
SaponinsAerial part of plantsSolvent extractionPhytochemical screeningResolve DOI
TanninsAerial part of plantsSolvent extractionPhytochemical screeningResolve DOI
1,8-cineoleLeavesSolvent extraction2.04 PercentGC-MSNo resolvable identifier
MyrceneLeavesSolvent extraction1.12 PercentGC-MSNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
SystemicSeedSolvent extractionHouse mouse (as animal)Acute toxicityResolve DOI

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Ambiguousbacterial gene mutation assayEscherichia coli (as organism)With and withoutResolve DOI
Ambiguousgene mutationbacterial reverse mutation assaySalmonella typhimurium (as organism)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Buriani, Alessandro., Fortinguerra, Stefano., Sorrenti, Vincenzo., Dall'Acqua, Stefano., Innocenti, Gabbriella., Montopoli, Monica., Gabbia, Daniela., Carrara, Maria. Human Adenocarcinoma Cell Line Sensitivity to Essential Oil Phytocomplexes from Pistacia Species: a Multivariate Approach . Molecules, 2017, vol. 22, no. 8. DOI
  2. Villar, A., Sanz, M.J., Paya, M. Hypotensive effect of pistacia lentiscus l. Pharmaceutical biology, 1987, vol. 25, no. 1, p. 1-3. DOI
  3. Bachrouch, Olfa., Jemaa, Jouda Mediouni-Ben., Talou, Thierry., Marzouk, Brahim., Abderraba, Manef. Fumigant toxicity of Pistacia lentiscus essential oil against Tribolium castaneum and Lasioderma serricorne . Bulletin of insectology, 2010, vol. 63, no. 1, p. 129-135.
  4. Bhouri, Wissem., Derbel, Safa., Skandrani, Ines., Boubaker, Jihed., Bouhlel, Ines., Sghaier, Mohamed B., Kilani, Soumaya., Mariotte, Anne M., Dijoux-Franca, Marie G., Ghedira, Kamel., Chekir-Ghedira, Leila. Study of genotoxic, antigenotoxic and antioxidant activities of the digallic acid isolated from Pistacia lentiscus fruits . Toxicology in vitro, 2010, vol. 24, no. 2, p. 509-515. DOI
  5. Alkofahi, A., Al-Khalil, S. Mutagenic and toxic activity of some Jordanian medicinal plants. International journal of pharmacognosy, 1995, vol. 33, no. 1, p. 61-64.
  6. Boukeloua, A., Belkhiri, A., Djerrou, Z., Bahri, L., Boulebda, N., Pacha, Y. Hamdi. ACUTE TOXICITY OF OPUNTIA FICUS INDICA AND PISTACIA LENTISCUS SEED OILS IN MICE. AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, 2012, vol. 9, no. 4, p. 607-611. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue